31 – 40 of 110
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson’s disease mouse model
(
- Contribution to journal › Article
-
Mark
Four Swedish cases of CSF1R-related leukoencephalopathy : Visualization of clinical phenotypes
(
- Contribution to journal › Article
-
Mark
The future of clinical trials for Alzheimer's disease. A blood-based biomarker perspective
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
New hallmarks of ageing : a 2022 Copenhagen ageing meeting summary
(
- Contribution to journal › Article
-
Mark
Emerging roles for dynamic aquaporin-4 subcellular relocalization in CNS water homeostasis
(
- Contribution to journal › Article
- 2021
-
Mark
Impact of differential and time-dependent autophagy activation on therapeutic efficacy in a model of Huntington disease
(
- Contribution to journal › Article
-
Mark
Pathological drivers of neurodegeneration in suspected non-Alzheimer’s disease pathophysiology
(
- Contribution to journal › Article
-
Mark
Editorial : Regeneration and Brain Repair
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Animal Models of Metabolic Disorders in the Study of Neurodegenerative Diseases : An Overview
(
- Contribution to journal › Scientific review
-
Mark
The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease
(
- Contribution to journal › Article